Inhibition of human platelet aggregation by nitric oxide donor drugs: Relative contribution of cGMP-independent mechanisms

Biochemical and Biophysical Research Communications

Volumn 279, Issue 2, 2000, Pages 412-419

  Sogo, N ^a   Magid, K S ^a   Shaw, C A ^a   Webb, D J ^a   Megson, I L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

ADP; cGMP; Collagen; Nitric oxide; Platelet aggregation; S nitrosothiols

Indexed keywords

ADENOSINE DIPHOSPHATE; CYCLIC GMP; DIETHYLAMINE DIAZENIUMDIOLATE; GLYCERYL TRINITRATE; HEMOGLOBIN; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; NITROSO DERIVATIVE; NITROSONIUM; PEROXYNITRITE; RIG 200; S NITROSOGLUTATHIONE; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME MECHANISM; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0034694667     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3976     Document Type: Article

References (36)

1. Comparative pharmacology of EDRF, NO and prostacyclin in platelets
2. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide
3. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
4. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
5. An L-arginine:nitric oxide pathway present in human platelets regulates aggregation
6. The pathogenesis of atherosclerosis: A perspective for the 1990s
7. Pharmacology of nitroglycerin and long-acting nitrates
8. Comparative effects of nitroprusside and nitroglycerin on platelet aggregation in patients with heart failure
9. The antiplatelet properties of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders
10. + as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO)
11. Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione
12. Stability of S-nitrosothiols in presence of copper, zinc-superoxide dismutase
13. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols
14. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide
15. Xanthine oxidase-mediated decomposition of S-nitrosothiols
16. Chemical mechanism underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-D,L-penicillamine and S-nitrosoglutathione
17. S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide
18. Nitric oxide/nucleophile complexes: A unique class of nitric oxide-based vasodilators
19. Measurement and modeling of nitric oxide release rates for nitric oxide donors
20. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione
21. Inhibition of platelet aggregation by S-nitrosocysteine via cGMP-independent mechanisms: Evidence of inhibition of thromboxane A2 synthesis in human blood platelets
22. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
23. Ca) in smooth muscle cells isolated from the rat mesenteric artery
24. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin, and by methylene blue in the rabbit aorta
25. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxodiazolo[4,3a]quinoxalino-1-one
26. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: Potential as a slow release nitric oxide donor drug
27. Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle cells
28. Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation
29. The formation of nitric oxide donors from peroxynitrite
30. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin
31. S-Nitrosylation of proteins with nitric oxide: Synthesis and characterisation of biologically active compounds
32. Nitric oxide-dependent and -independent effects on human platelets treated with peroxynitrite
33. Calcium entry mechanisms in human platelets
34. Peroxynitrite-induced tyrosine nitration and phosphorylation in human platelets
35. The effect of 1H-[1,2,4]oxadiazolo[4,3,a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide
36. Nitric oxide decreases cytosolic free calcium in Balb/c 3T3 fibroblasts by a cGMP-independent mechanism